Variant report
Variant | nsv875749 |
---|---|
Chromosome Location | chr2:209022909-209062388 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:209026800-209027000 | Enhancers | Fetal Brain Female | brain |
2 | chr2:209027200-209028200 | Weak transcription | Fetal Brain Female | brain |
3 | chr2:209028000-209028200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:209028000-209028400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr2:209028000-209028600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr2:209028000-209028600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr2:209028000-209028800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr2:209028200-209028600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr2:209028200-209028600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr2:209028200-209029600 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr2:209028200-209030400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr2:209028200-209030600 | Enhancers | Fetal Brain Female | brain |
13 | chr2:209028200-209031800 | Enhancers | Fetal Brain Male | brain |
14 | chr2:209028200-209033200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr2:209028600-209028800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr2:209028600-209029000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr2:209028600-209031600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
18 | chr2:209028600-209033400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
19 | chr2:209028600-209040400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
20 | chr2:209028800-209034800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
21 | chr2:209029000-209029400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
22 | chr2:209029400-209029600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr2:209029400-209029600 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
24 | chr2:209029800-209040000 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
25 | chr2:209030600-209040400 | Weak transcription | Fetal Brain Female | brain |
26 | chr2:209031600-209039400 | Strong transcription | Cortex derived primary cultured neurospheres | brain |
27 | chr2:209031800-209039800 | Weak transcription | Fetal Brain Male | brain |
28 | chr2:209032400-209032800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
29 | chr2:209032800-209040600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
30 | chr2:209033200-209037600 | Strong transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
31 | chr2:209033400-209033600 | Enhancers | K562 | blood |
32 | chr2:209033400-209033800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
33 | chr2:209033600-209036400 | Weak transcription | K562 | blood |
34 | chr2:209033600-209040000 | Weak transcription | Brain Germinal Matrix | brain |
35 | chr2:209034600-209035000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
36 | chr2:209034800-209035200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
37 | chr2:209035200-209040400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
38 | chr2:209036400-209036600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
39 | chr2:209036400-209036800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
40 | chr2:209036400-209037400 | Enhancers | Primary hematopoietic stem cells | blood |
41 | chr2:209036400-209037800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
42 | chr2:209036400-209037800 | Enhancers | K562 | blood |
43 | chr2:209036400-209038600 | Enhancers | Primary monocytes fromperipheralblood | blood |
44 | chr2:209036600-209037600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
45 | chr2:209036600-209037800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
46 | chr2:209036600-209038000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
47 | chr2:209036600-209040200 | Weak transcription | Brain Cingulate Gyrus | brain |
48 | chr2:209036800-209037000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
49 | chr2:209036800-209037200 | Flanking Active TSS | Primary hematopoietic stem cells short term culture | blood |
50 | chr2:209036800-209037400 | Bivalent Enhancer | HepG2 | liver |